[Breast cancer in clinical stage III. Multidisciplinary treatment].
The results of treatments applied to 142 patients with breast carcinoma stage III, in the Oncology Service from 1965 to 1974 are as follows: successive cycles of treatments were applied: irradiation with X-rays of 280 Kv-20 mA for ulcerated tumors or Cobalt 60 for non-ulcerated tumors, using a dose of 5,500 rad in eight weeks. Subsequently, in cases of residual neoplasia, mastectomy was used or an extra dose of 1,500 to 3,000 rad. Later, at the first sign of the spread of carcinoma, hormonal therapy was given and then chemotherapy. Survival rate after five years was as follows: 41.54% of patients survived and 58.45% died from the cancer.
Molina-Esquivel
J
J
Servicio de Oncología del Hospital 20 de Noviembre, Instituto de Seguridad Social, México, D.F.
Vargas Sandoval
G
G
García Siller
I
I
Velázquez López
J
J
Soto de León
M
M
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001943:Breast Neoplasms / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009367:Neoplasm Staging; D012189:Retrospective Studies; D015996:Survival Rate; D016896:Treatment Outcome
Cáncer mamario en estadío clínico III. Tratamiento multidisciplinario.